Takeda Announces US Head Kim to Replace Weber as CEO
Takeda Pharmaceutical Co.’s board has selected Julie Kim, the head of the company’s US unit, to replace Christophe Weber as ...
Japan's Takeda raises full-year forecast after Q3 profit trails forecast
Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...
Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, ...
Japan's Takeda says Q3 profit slid 38%, trailing analyst estimates
Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates, as ...
Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth
Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024) showing continued advancement of its Growth & Launch ...
Wall Street Journal13m
Takeda Pharmaceutical Raises Earnings Guidance, Names Julie Kim as New CEO
Takeda Pharmaceutical 45020.65%increase; green up pointing triangle raised its annual earnings forecasts despite posting lower quarterly net profit, and it said Julie Kim, who heads its U.S. business ...
Japan's Takeda says CEO Weber to step down, raises profit forecast
Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after 12 years in management at Japan's biggest drugmaker. Julie Kim, president of the company's U.S. unit, was named to ...
Takeda Pharmaceutical (TAK) Projected to Post Quarterly Earnings on Thursday
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) is projected to announce its earnings results before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of ...
Takeda Pharmaceutical Expected to Post Lower Third-Quarter Net Profit -- Earnings Preview
NET PROFIT FORECAST: Takeda is expected to post a 59% drop in net profit to 43.58 billion yen, equivalent to $280.2 million, for the three months ended Dec. 31, according to a poll of analysts by data ...
Le Lézard2m
Novo Nordisk Foundation granted DKK 10 billion (?1.35 billion) to benefit people and the planet in milestone year
In 2024, on its 100th anniversary, the Novo Nordisk Foundation reached a new milestone, awarding close to DKK 10.1 billion (?1.35 billion) to support nearly 1,800 new projects aimed at improving ...
Takeda Canada Announces Héma-Québec's Addition Of HyQvia To Plasma Product List
Takeda Canada Inc., the Canadian organization of Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that non-profit ...
Le Lézard32m
Grains of Truth 2024 - Global Insights on Healthy and Sustainable Food Systems
The Grains of Truth 2024 report, released today by EAT and GlobeScan, reveals a mixed picture of progress towards a plant-based future. While 68% of people globally express a desire to eat more ...